Erdafitinib is a targeted therapy. It’s used to treat metastatic urothelial carcinoma that has FGFR2/3 alterations. It’s made to block FGFR signaling.
This is important because it helps cancer cells grow and spread. You can get this med in film-coated tablets. They come in strengths of 3 mg, 4 mg, or 5 mg.
The suggested starting dose is 8 mg, taken once a day. But it might go up to 9 mg if the patient does okay with it and their body responds well. The product comes in bottles.
Each one has 56 tablets.
Reviews
There are no reviews yet.